SC 13G Filing

Company

LIGAND PHARMACEUTICALS INC

Filed

November 7, 2008

Accession Number

0000898432-08-001137

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →